Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus

Journal of Proteomics

Volumn 76, Issue , 2012, Pages 287-296

  Shai, Ela ^a   Rosa, Isaac ^b,c   Parguiña, Andrés F ^b,c   Motahedeh, Sarah ^a   Varon, David ^a   García, Ángel ^b,c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c NONE   (Spain)

Author keywords

Microparticles; Platelets; Proteomics

Indexed keywords

ADAPTOR PROTEIN; ALPHA6 INTEGRIN; DOK2 PROTEIN; FUNCTIONAL GROUP; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; PROTEOME; SIGNAL PEPTIDE; THROMBIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INGENUITY PATHWAYS ANALYSIS SOFTWARE; MASS SPECTROMETRY; OPEN READING FRAME; PARTICLE SIZE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEOMICS; SHEAR STRESS; SIGNAL TRANSDUCTION; STIMULUS; THROMBOCYTE; THROMBOCYTE ACTIVATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; FEMALE; HUMANS; MALE; PLATELET ACTIVATION; PROTEOME;

EID: 84869869895     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.02.030     Document Type: Article

References (32)

1. Siljander P.R. Platelet-derived microparticles - an updated perspective. Thromb Res 2011, 127:S30-S33.
2. Diamant M., Tushuizen M.E., Sturk A., Nieuwland R. Cellular microparticles: new players in the field of vascular disease?. Eur J Clin Invest 2004, 34:392-401.
3. Varon D., Shai E. Role of platelet-derived microparticles in angiogenesis and tumor progression. Discov Med 2009, 8:237-241.
4. Shantsila E., Kamphuisen P.W., Lip G.Y. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 2010, 8(11):2358-2368.
5. García A., Prabhakar S., Hughan S.C., Anderson T.W., Brock C.J., Pearce A.C., et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood 2004, 103:2088-2095.
6. García A., Senis Y.A., Antrobus R., Hughes C.E., Dwek R.A., Watson S.P., et al. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 2006, 6:5332-5343.
7. Senis Y.A., Antrobus R., Severin S., Parguiña A.F., Rosa I., Zitzmann N., et al. Proteomic analysis of integrin αIIbβ3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions. J Thromb Haemost 2009, 7(10):1718-1726.
8. Coppinger J.A., Cagney G., Toomey S., Kislinger T., Belton O., McRedmond J.P., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103:2096-2104.
9. García B.A., Smalley D.M., Cho H., Shabanowitz J., Ley K., Hunt D.F. The platelet microparticle proteome. J Proteome Res 2005, 4:1516-1521.
10. Dean W.L., Lee M.J., Cummins T.D., Schultz D.J., Powell D.W. Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost 2009, 102:711-718.
11. Pérez-Pujol S., Marker P.H., Key N.S. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry A 2007, 71:38-45.
12. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
13. García A., Prabhakar S., Brock C.J., Pearce A.C., Dwek R.A., Watson S.P., et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2004, 4:656-668.
14. Tadokoro S., Shattil S.J., Eto K., Tai V., Liddington R.C., de Pereda J.M., et al. Talin binding to integrin β tails: a final common step in integrin activation. Science 2003, 302:103-106.
15. Yano Y., Shiba E., Kambayashi J., Sakon M., Kawasaki T., Fujitani K., et al. The effects of calpeptin (a calpain specific inhibitor) on agonist induced microparticle formation from the platelet plasma membrane. Thromb Res 1993, 71:385-396.
16. Yan R., Wang Z., Yuan Y., Cheng H., Dai K. Role of camp-dependent protein kinase in the regulation of platelet procoagulant activity. Arch Biochem Biophys 2009, 485:41-48.
17. Piccin A., Murphy W.G., Smith O.P. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007, 21:157-171.
18. Flaumenhaft R., Dilks J.R., Richardson J., Alden E., Patel-Hett S.R., Battinelli E., et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 2009, 113:1112-1121.
19. Smalley D.M., Root K.E., Cho H., Ross M.M., Ley K. Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb Haemost 2007, 97:67-80.
20. Kim H.K., Song K.S., Chung J.H., Lee K.R., Lee S.N. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004, 124:376-384.
21. Boulanger C.M., Amabile N., Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006, 48:180-186.
22. Preston R.A., Jy W., Jimenez J.J., Mauro L.M., Horstman L.L., Valle M., et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003, 41:211-217.
23. Diehl P., Nagy F., Sossong V., Helbing T., Beyersdorf F., Olschewski M., et al. Increased levels of circulating microparticles in patients with severe aortic valve stenosis. Thromb Haemost 2008, 99:711-719.
24. Jy W., Horstman L.L., Jimenez J.J., Ahn Y.S., Biró E., Nieuwland R., et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004, 2:1842-1851.
25. García A. Two-dimensional gel electrophoresis in platelet proteomics research. Methods Mol Med 2007, 139:339-353.
26. Hayashi M., Suzuki H., Kawashima S., Saido T.C., Inomata M. The behavior of calpain-generated N- and C-terminal fragments of talin in integrin-mediated signaling pathways. Arch Biochem Biophys 1999, 371:133-141.
27. Xiao H., Jepkorir C.J., Harvey K., Remick D.G. Thrombin-induced platelet microparticles improved the aggregability of cryopreserved platelets. Cryobiology 2002, 44:179-188.
28. Inoue O., Suzuki-Inoue K., McCarty O.J., Moroi M., Ruggeri Z.M., Kunicki T.J., et al. Laminin stimulates spreading of platelets through integrin α6β1-dependent activation of GPVI. Blood 2006, 107:1405-1412.
29. Primo L., Seano G., Roca C., Maione F., Gagliardi P.A., Sessa R., et al. Increased expression of α6 integrin in endothelial cells unveils a proangiogenic role for basement membrane. Cancer Res 2010, 70:5759-5769.
30. Bouvard C., Gafsou B., Dizier B., Galy-Fauroux I., Lokajczyk A., Boisson-Vidal C., et al. α6-integrin subunit plays a major role in the proangiogenic properties of endothelial progenitor cells. Arterioscler Thromb Vasc 2010, 30:1569-1575.
31. Morel O., Morel N., Freyssinet J.M., Toti F. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 2008, 19:9-23.
32. Master Z., Jones N., Tran J., Jones J., Kerbel R.S., Dumont D.J. Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of PAK. EMBO J 2001, 20:5919-5928.